Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity

dc.contributor.author	Fjeldbo, Christina Sæten
dc.contributor.author	Hompland, Tord
dc.contributor.author	Hillestad, Tiril
dc.contributor.author	Aarnes, Eva-Katrine
dc.contributor.author	Günther, Clara-Cecilie
dc.contributor.author	Kristensen, Gunnar S Balle
dc.contributor.author	Malinen, Eirik
dc.contributor.author	Lyng, Heidi
dc.date.accessioned	2021-02-09T07:40:30Z
dc.date.available	2021-02-09T07:40:30Z
dc.date.created	2020-07-21T08:57:01Z
dc.date.issued	2020
dc.identifier.citation	EBioMedicine. 2020, 57 .
dc.identifier.issn	2352-3964
dc.identifier.uri	https://hdl.handle.net/11250/2726737
dc.language.iso	eng
dc.title	Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
dc.type	Peer reviewed
dc.type	Journal article
dc.description.version	publishedVersion
cristin.ispublished	true
cristin.fulltext	original
cristin.qualitycode	1
dc.identifier.doi	10.1016/j.ebiom.2020.102841
dc.identifier.cristin	1819960
dc.source.journal	EBioMedicine
dc.source.volume	57
dc.source.pagenumber	0